NCT00153790

Brief Summary

The primary aim is to examine whether the intake of PhosphoLEAN is effective in aiding a cohort of women in losing weight. Participants taking the supplement will have significantly greater improvement in study outcomes than those taking the placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Apr 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2005

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2005

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 12, 2005

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2006

Completed
Last Updated

March 13, 2014

Status Verified

March 1, 2014

First QC Date

September 7, 2005

Last Update Submit

March 12, 2014

Conditions

Weight Loss

Keywords

green teaweightwomen

Outcome Measures

Primary Outcomes (2)

  • Weight Loss

  • Appetite Suppression

Interventions

PhosphoLeanDRUG

Eligibility Criteria

Age30 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years, women, overweight or obese class I, premenopausal, maintain current diet and exercise regimen

You may not qualify if:

  • pregnant or planning to become pregnant, currently have or history of cancer, heart disease, anemia, diabetes, depression

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Cooper Institute

Dallas, Texas, 75230, United States

Location

MeSH Terms

Conditions

Weight LossBody Weight

Condition Hierarchy (Ancestors)

Body Weight ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Conrad Earnest, PhD

    The Cooper Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 7, 2005

First Posted

September 12, 2005

Study Start

April 1, 2005

Study Completion

May 1, 2006

Last Updated

March 13, 2014

Record last verified: 2014-03

Locations

US(1)